-+ 0.00%
-+ 0.00%
-+ 0.00%

Kymera COO Jeremy Chadwick disposes 300 shares for $27,000

PUBT·04/24/2026 20:32:08
Listen to the news
Kymera COO Jeremy Chadwick disposes 300 shares for $27,000
  • Kymera Therapeutics Chief Operating Officer Jeremy G. Chadwick reported sale of 300 shares of common stock at USD 90 on April 22, 2026.
  • Transaction also included option exercises totaling 300 shares at USD 30.17 and USD 43.5.
  • Chadwick held 61,202 shares of Kymera common stock following transactions.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Kymera Therapeutics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001193125-26-177400), on April 24, 2026, and is solely responsible for the information contained therein.